Links between pain and depression;Zwia̧zki miȩdzy bólem a depresja̧

Psychiatria Polska

Volumn 39, Issue 1, 2005, Pages 7-20

  Rabe Jabłońska, Jolanta ^a,b   Miller, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Katedra Psychiatrii   (Poland)

Author keywords

Depression; Links; Pain

Indexed keywords

NEUROPEPTIDE; NEUROTRANSMITTER;

CHOLINERGIC SYSTEM; CHRONIC PAIN; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; HUMAN; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PAIN; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; STRESS; SYMPTOMATOLOGY; CHRONIC DISEASE; NERVE TRACT; PATHOPHYSIOLOGY; SOMATOFORM DISORDER;

CHRONIC DISEASE; DEPRESSIVE DISORDER; HUMANS; NEURAL PATHWAYS; PAIN; RISK FACTORS; SOMATOFORM DISORDERS;

EID: 14944341946     PISSN: 00332674     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Classification of chronic pain. Description of chronic pain syndromes and definitions of pain terms. International Association for the Study of Pain. Subcomittee on Taxonomy. Pain 1986; 35: 874-876.
2. Craig AD, Reiman EM, Evans A, Bushnell MC. Functional imaging of an illusion of pain. Nature 1999; 384: 258.
3. Dolin SJ, Padfield NL, Pateman JA. Pain clinic manual. Oxford: Butterworth-Heinemann; 1996.
4. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramok JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicci GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NMJ. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998; 281: 1640-1669.
5. Melzack R, Wall PD. Pain mechanisms: A new theory. Science 1965; 150: 971-993.
6. Sarno JE. Healing back pain. New York: Warner Books; 1991.
7. Tolle TR, Kaufmann T, Siessmeier T, Lautenbacher S, Berthele A, Munz F, Zieglgansberger W, Willoch F, Schwaiger M, Conrad B, Bartenstein P. Region-specific encoding of sensory and affective components of pain in the human brain: A positron emission tomography correlation analysis. Ann. Neurol. 1999; 45: 40-48.
8. Wahlestedt C. Reward for persistence in substance P research. Science 1998; 281: 1624-1639.
9. Zeltzer L, Bursch B, Walco G. Pain responsiveness and chronic pain: A psychobiological perspective. Dev. Behav. Pediatr. 1997; 18: 413-421.
10. Fishbain DA, Cutler R, Rosomoff H, Rosomoff RS. Chronic pain - associated depression: antecedent or consequence of chronic pain? A review. Clin. J. Pain 1997; 13: 116-137.
11. Magni G. On the relationship between chronic pain and depression when there is no organic lesion. Pain 1987; 31: 1-21.
12. Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol. Bull. 1985; 97: 18-34.
13. France RD. Psychiatric aspects of pain. Clin. J. Pain 1989; 5 (supl. 2): 35-42.
14. Dickens C, McGowan L, Dale S. Impact of depression on experimental pain perception: a systematic review of the literature with meta-analysis. Psychosom. Med. 2003; 65: 369-375.
15. Dworkin RH, Gitlin MJ. Clinical aspects of depression in chronic pain patients. Clin. J. Pain 1991; 7: 79-94.
16. Magni G, Marchetti M, Moreschi CL, Merskey H, Luchini SR. Chronic muscnlosceletal pain and depressive symptoms in the National Health and Nutrition Examination. International epidemiological follow-up study. Pain 1993; 53: 163-168.
17. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch. Gen. Psychiatry 2003; 60: 140-144.
18. Gureje O, Von Korff, Simon GE, Gater R. Persistent pain and well-being: World Health Organization Study in Primary Care. JAMA 1998; 280: 147-151.
19. Krause SJ, Wiener RL, Tait RC. Depression and pain behavior in patients with chronic pain. Clin. J. Pain 1994; 10: 122-127.
20. Kudoh A, Katagai H, Takazawa T: Small-dose ketamine improves the postoperative state of depressed patients. Anesth. Analg. 2002; 95: 114-118.
21. Von Korff M, Simon G. The relationship between pain and depression. Brit. J. Psychiatry 1996; 168 (supl. 30): 101-108.
22. de Walden-Gałuszko K. Ból a depresja. Dysk. Depr. 2002; 21: 5-9.
23. Lautenbacher S, Spernal J, Strian D, Fassbender K, Krumrey K, Krieg JC. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom. Med. 1999; 61: 822-887.
24. Mico JA, Rojas-Corrales MO, Berrocoso E, Elorza J. The pathophysiology of pain in depression. JECNP 2003; 13 (supl. 4): 98.
25. Gureje O, Simon GE, Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain 2001; 92: 195-200.
26. Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom. Med. 2002; 64: 773-786.
27. Landowski J. Stres w patogenezie zaburzeń psychicznych. Post. Psychiatr. Neurol. 2002; 11 (supl. 3): 7-17.
28. Kessler RC. The effects of stressful life events on depression. Ann. Rev. Psychol. 1997; 48: 191-214.
29. Korszun A. Facial pain, depression and stress - connections and directions. J. Oral Pathol. Med. 2002; 31: 615-619.
30. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: a diathesis - stress framework. Psycholl. Bull. 1996; 1: 95-110.
31. Mc Berth J, MacFarlane GJ, Silman AJ. Does chronic pain predict future psychological distress? Pain 2002; 96: 239-245.
32. Landowski J. Depresja jako przewlekty stres. Dysk. Depr. 2001; 17: 2-6.
33. Pużyński S. Neurobiologia chorób afektywnych. CML - Psychiatr. 2001; 3: 53-61.
34. Neeck G, Reidel W. Hormonal perturations in fibromyalgia syndrome. Ann. NY Acad. Sci 1999; 879: 325-338.
35. Lieb K, Ahlvers K, Dancker K. Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacol 2002; 27: 1041-1049.
36. Rupniak NM, Kramer MS. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK[sub1]) agonists. Trends Pharmacol. Sci. 1999; 20: 485-490.
37. Rupniak NM. Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists. Curr. Op. Invest. Drugs 2002; 3: 257-261.
38. Steinberg R, Alonso R, Griebel G, Bert L, Jung M, Oury-Donat F, Poncelet M, Gueudet C, Desvignes C, Le Fur G, Soubrie P. Selective blocade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced cortocotropin-releasing factor function. J. Pharmacol. Exp. Ther. 2001; 299: 449-458.
39. Bair MJ, Robinson RL, Katon W, Kroenke K. Depresion and pain comorbidity. Arch. Intern. Med. 2003; 163: 2433-2445.
40. Dobrogowski J, Wordliczek J, red. Ból przewlekły. Kraków: Wydawnictwo MCKP UJ; 2002, s. 23-25, 37-38.
41. Hakeberg M, Hallberg LR, Berggren U. Burning mouth syndrome: experiences from the prospective of female patients. Eur. J. Oral. Sci. 2003; 111: 305-311.
42. Jaaskelainen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, Bergman J. Role of the dopaminergic system in chronic pain - a fluomdopa - PET study. Pain 2001; 15: 257-260.